New research highlighted by Vance Health Hub suggests that higher consumption of ultra-processed foods may be associated with an increased risk of relapse in people living with Crohn’s disease. The findings, reported by the European Medical Journal (EMJ), point to potential disruption of the gut microbiome and increased intestinal permeability as possible explanations, adding to a growing body of evidence examining diet as a modifiable factor in inflammatory bowel disease (IBD).
Background
Crohn’s disease follows a relapsing and remitting course, and clinicians have long sought to understand which factors, beyond medication adherence, influence the likelihood of flares. Diet has become an area of particular interest, given the rising consumption of ultra-processed foods across Western populations. These products, typically classified using the NOVA food classification system, are industrially formulated and often contain additives, emulsifiers, and preservatives not found in minimally processed foods. Previous research has explored possible links between ultra-processed food intake and the development of IBD, as well as other gastrointestinal and metabolic conditions, making relapse specifically in established Crohn’s disease a natural extension of this line of enquiry.
Key findings
According to the EMJ report, researchers examined the relationship between ultra-processed food consumption and disease relapse among people with Crohn’s disease, finding that greater intake of these foods was associated with a higher likelihood of flares. The study background cited by EMJ noted that proposed mechanisms include alterations to the gut microbiome and increased intestinal permeability, sometimes described as a weakening of the gut’s protective barrier, both of which are thought to play a role in perpetuating intestinal inflammation. The original reporting did not specify detailed statistical outputs, cohort size, or study design in the material available to Vance Health Hub, and these details could not be independently verified at the time of writing. The overall direction of the finding, however, aligns with a broader pattern in nutritional gastroenterology research linking processed food consumption to gastrointestinal disease activity.
Clinical relevance
For clinicians, dietitians, and patients managing Crohn’s disease, this research adds weight to ongoing discussions about the role of food processing, rather than nutrient content alone, in disease behaviour. If confirmed by further studies with detailed methodology, the findings could eventually inform how dietitians counsel patients during periods of remission. At this stage, the evidence should be regarded as observational and associative rather than proof of a direct causal pathway, and any dietary adjustments should continue to be made in consultation with an IBD dietitian or gastroenterology team rather than based on this finding alone.
Reference
The primary study underlying this report could not be fully identified from the material available. The information in this article is drawn from: Ultra-Processed Foods Associated with Crohn’s Disease Relapse. EMJ Reviews [online]. Available at: https://www.emjreviews.com/gastroenterology/news/ultra-processed-foods-associated-with-crohns-disease-relapse/
This article is a journalistic summary for informational purposes only. It does not constitute clinical advice or a recommendation to alter treatment decisions.